Publicaciones (30) Publicaciones de GORANE EUBA UGARTE

2023

  1. Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial

    Nature Medicine, Vol. 29, Núm. 10, pp. 2518-2525

2021

  1. Angiosarcoma de cara y cuero cabelludo

    Revista Española de Casos Clínicos en Medicina Interna (RECCMI), Vol. 6, Núm. 2, pp. 2-4

  2. Multicentre, randomised, open-label, phase IV-III study to evaluate the efficacy of cloxacillin plus fosfomycin versus cloxacillin alone in adult patients with methicillin-susceptible Staphylococcus aureus bacteraemia: Study protocol for the SAFO trial

    BMJ Open, Vol. 11, Núm. 8

2019

  1. The different microbial etiology of prosthetic joint infections according to route of acquisition and time after prosthesis implantation, including the role of multidrug-resistant organisms

    Journal of Clinical Medicine, Vol. 8, Núm. 5

2016

  1. Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: a randomised clinical trial

    International Journal of Antimicrobial Agents, Vol. 48, Núm. 3, pp. 310-316

  2. Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study

    Clinical Microbiology and Infection, Vol. 22, Núm. 8, pp. 732.e1-732.e8

2014

  1. Characteristics of prosthetic joint infections due to Enterococcus sp. and predictors of failure: A multi-national study

    Clinical Microbiology and Infection, Vol. 20, Núm. 11, pp. 1219-1224

  2. Gram-negative prosthetic joint infection: Outcome of a debridement, antibiotics and implant retention approach. A large multicentre study

    Clinical Microbiology and Infection, Vol. 20, Núm. 11, pp. O911-O919

  3. Prevention of staphylococcus epidermidis biofilm formation using electrical current

    Journal of Applied Biomaterials and Functional Materials, Vol. 12, Núm. 2, pp. 81-83

2013

  1. Infected hip hemiarthroplasties and total hip arthroplasties: Differential findings and prognosis

    Journal of Infection, Vol. 67, Núm. 6, pp. 536-544

  2. Linezolid in late-chronic prosthetic joint infection caused by gram-positive bacteria

    Diagnostic Microbiology and Infectious Disease, Vol. 76, Núm. 1, pp. 93-98

2011

  1. Changing Trends in the Epidemiology of Pyogenic Vertebral Osteomyelitis: The Impact of Cases with No Microbiologic Diagnosis

    Seminars in Arthritis and Rheumatism, Vol. 41, Núm. 2, pp. 247-255

  2. Clinical outcome and microbiological findings using antibiotic-loaded spacers in two-stage revision of prosthetic joint infections

    Journal of Infection, Vol. 63, Núm. 1, pp. 23-31

  3. Early prosthetic joint infection: Outcomes with debridement and implant retention followed by antibiotic therapy

    Clinical Microbiology and Infection, Vol. 17, Núm. 11, pp. 1632-1637

  4. Efficacy of tigecycline alone and with rifampin in foreign-body infection by methicillin-resistant Staphylococcus aureus

    Journal of Infection, Vol. 63, Núm. 3, pp. 229-235

  5. Treatment with linezolid or vancomycin in combination with rifampin is effective in an animal model of methicillin-resistant Staphylococcus aureus foreign body osteomyelitis

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 3, pp. 1182-1186

2010

  1. Acute haematogenous prosthetic joint infection: Prospective evaluation of medical and surgical management

    Clinical Microbiology and Infection, Vol. 16, Núm. 12, pp. 1789-1795

  2. Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 12, pp. 5251-5256

2009

  1. Efficacy of high doses of daptomycin versus alternative therapies against experimental foreign-body infection by methicillin-resistant Staphylococcus aureus

    Antimicrobial Agents and Chemotherapy, Vol. 53, Núm. 10, pp. 4252-4257

  2. High doses of levofloxacin vs moxifloxacin against staphylococcal experimental foreign-body infection: The effect of higher MIC-related pharmacokinetic parameters on efficacy

    Journal of Infection, Vol. 58, Núm. 3, pp. 220-226